Cargando…

Management of Myositis-Associated Interstitial Lung Disease

Idiopathic inflammatory myopathies, including polymyositis (PM), dermatomyositis (DM), and clinically amyopathic DM (CADM), are a diverse group of autoimmune diseases characterized by muscular involvement and extramuscular manifestations. Interstitial lung disease (ILD) has major pulmonary involveme...

Descripción completa

Detalles Bibliográficos
Autor principal:	Fujisawa, Tomoyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065549/ https://www.ncbi.nlm.nih.gov/pubmed/33916864 http://dx.doi.org/10.3390/medicina57040347

Ejemplares similares

“Management of myositis associated interstitial lung disease”
por: Thong, Lorraine, et al.
Publicado: (2023)

Prognostic Factors for Myositis-Associated Interstitial Lung Disease
por: Fujisawa, Tomoyuki, et al.
Publicado: (2014)

Myositis interstitial lung disease and autoantibodies
por: Chaudhry, Shire, et al.
Publicado: (2023)

High-Resolution CT Findings of Myositis-Related Interstitial Lung Disease
por: Egashira, Ryoko
Publicado: (2021)

Analytic Morphomics in Myositis-Related Interstitial Lung Disease
por: O’Mahony, Alexander T., et al.
Publicado: (2023)

Myositis-Related Interstitial Lung Disease: A Respiratory Physician’s Point of View
por: Waseda, Yuko
Publicado: (2021)

Clinical features and outcomes of patients with myositis associated-interstitial lung disease
por: Karampitsakos, Theodoros, et al.
Publicado: (2023)

A New Method for the Assessment of Myalgia in Interstitial Lung Disease: Association with Positivity for Myositis-Specific and Myositis-Associated Antibodies
por: Sambataro, Gianluca, et al.
Publicado: (2022)

Significance of Myositis Autoantibody in Patients with Idiopathic Interstitial Lung Disease
por: Song, Ju Sun, et al.
Publicado: (2015)

In adult onset myositis, the presence of interstitial lung disease and myositis specific/associated antibodies are governed by HLA class II haplotype, rather than by myositis subtype
por: Chinoy, Hector, et al.
Publicado: (2006)

Anti Jo-1 myositis. 'Mechanic's hands' and interstitial lung disease.
por: Taggart, A. J., et al.
Publicado: (2002)

Predictive Features and Clinical Presentation of Interstitial Lung Disease in Inflammatory Myositis
por: Vojinovic, Tamara, et al.
Publicado: (2020)

Assessment of Optimal Screening Tests for the Detection of an Inflammatory Myositis-associated Interstitial Lung Disease
por: Castillo, Sonia, et al.
Publicado: (2020)

Prevalence and clinical associations of myositis antibodies in a large cohort of interstitial lung diseases
por: Moll, Sofia A., et al.
Publicado: (2022)

Interstitial lung disease associated with inflammatory myositis: Autoantibodies, clinical phenotypes, and progressive fibrosis
por: Ceribelli, Angela, et al.
Publicado: (2023)

Lung transplantation for interstitial lung disease in idiopathic inflammatory myositis: A cohort study
por: Rivière, Amélie, et al.
Publicado: (2022)

Asymptomatic necrotizing myositis in a young male with progressive interstitial lung disease
por: Baah, Samantha, et al.
Publicado: (2021)

Elevated α-defensin levels in plasma and bronchoalveolar lavage fluid from patients with myositis-associated interstitial lung disease
por: Sakamoto, Noriho, et al.
Publicado: (2018)

Inflammatory myositis-associated interstitial lung disease can be distinguished from that associated with other connective tissue diseases
por: Nurmi, Hanna M., et al.
Publicado: (2023)

Interstitial Lung Disease in Dermatomyositis Without Myositis-Specific and Myositis-Associated Autoantibodies: Study of a Series of 72 Patients From a Single Cohort
por: Chen, Fang, et al.
Publicado: (2022)

Interstitial lung disease is a dominant feature in patients with circulating myositis-specific antibodies
por: Misra, Abhinav K., et al.
Publicado: (2021)

Prevalence of Novel Myositis Autoantibodies in a Large Cohort of Patients with Interstitial Lung Disease
por: Moll, Sofia A., et al.
Publicado: (2020)

Evaluation of usefulness in surfactant protein D as a predictor of mortality in myositis-associated interstitial lung disease
por: Kaieda, Shinjiro, et al.
Publicado: (2020)

Treatment Outcomes of Infectious and Non-infectious Acute Exacerbation of Myositis-Related Interstitial Lung Disease
por: Lee, Hyun, et al.
Publicado: (2022)

Serologic phenotypes distinguish systemic lupus erythematosus patients developing interstitial lung disease and/or myositis
por: Cotton, Thaisa, et al.
Publicado: (2022)

Lung ultrasound B-lines and serum KL-6 correlate with the severity of idiopathic inflammatory myositis-associated interstitial lung disease
por: Wang, Yukai, et al.
Publicado: (2020)

Diagnosis and management of interstitial lung disease
por: Meyer, Keith C
Publicado: (2014)

Management of Fibrosing Interstitial Lung Diseases
por: Maher, Toby M., et al.
Publicado: (2019)

Pneumothorax in connective tissue disease-associated interstitial lung disease
por: Nishimoto, Koji, et al.
Publicado: (2020)

Myositis autoantibodies in Korean patients with inflammatory myositis: Anti-140-kDa polypeptide antibody is primarily associated with rapidly progressive interstitial lung disease independent of clinically amyopathic dermatomyositis
por: Kang, Eun Ha, et al.
Publicado: (2010)

Korean Guidelines for Diagnosis and Management of Interstitial Lung Diseases: Part 5. Connective Tissue Disease Associated Interstitial Lung Disease
por: Koo, So-My, et al.
Publicado: (2019)

Management of Cancer-Associated Myositis
por: Selva-O’Callaghan, Albert, et al.
Publicado: (2022)

Detection and Management of Interstitial Lung Diseases Associated With Connective Tissue Diseases
por: Castelino, Flavia V., et al.
Publicado: (2021)

Management of patients with fibrosing interstitial lung diseases
por: Morrow, Lee E, et al.
Publicado: (2021)

Mortality Risk Stratification Using Cluster Analysis in Patients With Myositis-Associated Interstitial Lung Disease Receiving Initial Triple-Combination Therapy
por: Gono, Takahisa, et al.
Publicado: (2022)

State of the art in the diagnosis and management of interstitial lung disease
por: BUZAN, MARIA T. A., et al.
Publicado: (2015)

Diagnosis and Pharmacologic Management of Fibrotic Interstitial Lung Disease
por: Berger, Kristin, et al.
Publicado: (2023)

Predicting Survival Across Acute Exacerbation of Interstitial Lung Disease in Patients with Idiopathic Inflammatory Myositis: The GAP-ILD Model
por: Cao, Heng, et al.
Publicado: (2020)

Phenotypic clusters and survival analyses in interstitial pneumonia with myositis-specific autoantibodies
por: Lia, Yihua, et al.
Publicado: (2021)

Management of interstitial lung disease in patients with autoimmune disease-related interstitial lung disease
por: Dsouza, Kevin G., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2vpl0r9420vrs8qolicbi5oa73